MicroRNAs (miRNAs) 
Introduction miRNAs are short non-coding RNAs, 18-25 nucleotides in length, which regulate gene expression. In the view of their complementarity with 3' untranslated region (3Ј-UTR) of target mRNA, functional effects of miRNAs are provided by two mechanisms: by post-transcriptional regulation of gene expression leading to target mRNA degradation or repression of its translation with consequent decrease of particular protein levels or on the contrary by up-regulation of their targets. Bioinformatic approach was used previously for prediction of capacity of miRNAs to regulate approximately half of the mammalian genes, with significant number of important oncogenes and tumour suppressor genes involved
. miRNAs have been studied most intensively in the field of oncological research, and emerging evidence suggests that altered miRNA regulation is involved in the pathogenesis of cancer [3] [4] [5] [6] . Changes in the expression of miRNAs have been observed in a variety of human solid cancers [7, 8] : breast [9, 10] , colorectal [11, 12] , lung [13, 14] , kidney [15, 16] , prostate [17] , cervical [18] , gastric [19] , bladder [20] , pancreatic [21] , [22] , head and neck [23] , thyroid [24] and ovarian cancer [25] , hepatocellular carcinoma [26] and glioma [27, 28] . In addition, approximately 50% of all annotated human miRNA genes are located in fragile sites or areas of the genome that are frequently associated with cancer [29] . Up [30] . The initial demonstration that miRNA-related SNPs can affect phenotype was elegantly provided by Abelson et al. who found that a mutation in the miR-189-binding site of SLITRK1 was associated with Tourette's syndrome [31] . The first evidence that point mutations in miRNA genes may affect function and result in cancer susceptibility comes from a pioneering study conducted by Carlo Croce's group in which a germline mutation in pri-mir-16-1 resulted in low levels of miR-16-1 expression in familial chronic lymphocytic leukaemia [32, 33] . Since then, several studies have used systematic sequencing or in silico approaches to identify SNPs in miRNArelated genes, catalogues of which have been created and published [34] [35] [36] . Taken together, these facts provide sufficient theoretical basis for follow-up case-control studies to determine the association between such genetic markers and cancer risk. This study provides brief outlook on miRNA biogenesis, biology and the functional effects of miRNA-related SNPs, and-to the best of our knowledge-a complete summary of case-control studies performed in the field of solid cancer and miRNA SNPs.
Classification of miRNA-related SNPs
SNPs have been widely implicated in cancer development [37, 38] [39, 40] . SNPs summarized in Table 1 [39, 40] . [43] .
SNPs in pri-, pre-, mat-miRNAs
There are two possible mechanistic consequences of presence of SNPs within miRNA-binding region [32] : (1) 
Breast cancer
Breast cancer is the leading cause of cancer-related death in women and the second most common cancer in the world after lung cancer. As up to 10% of the total number of women diagnosed with breast cancer report a family history, miRNAs [9, 10] mature form as well as to its diminished capacity to regulate target genes [46] . On the contrary, the study conducted by Catucci et al. (2010) on 1894 German and Italian familial breast cancer cases suggested a lack of association between SNPs rs11614913 and both breast cancer risk and age at breast cancer onset [47] .
A G to C polymorphism (rs2910164) located within the sequence of a miR-146a precursor, which leads to a change from a G:U pair to a C:U mismatch in its stem region was primarily studied by Shen et al. (2008) [48] [48] . Unfortunately, the association of rs2910164 and breast cancer was not confirmed in further larger studies by Hu et al. (2008) and Catucci et al. (2010 [54] .
There are also several experimentally evaluated miRNA-related SNPs lacking association with breast cancer risk or clinical outcome rs12983273 in miR-373 [49] , rs3807348 in miR-335 [49] , rs731085 in let-7a-3 [49] and rs2292832 in miR-149 [45] . 15 
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Colorectal cancer
Several genome-wide profiling studies described dysregulation of miRNAs in colorectal cancer (CRC) tissue and blood serum [11, 12] [55] .
A study of Lee et al. [56] [56] . [57] . [58] . [61] .
included 426 consecutive Korean patients with surgically treated CRC: 40 polymorphisms in miRNArelated genes were determined. In a univariate analysis, the progression-free survival of the patients with the combined miR-492 C/G and G/G genotype was significantly worse than that of the patients with the mir-492 C/C genotype (rs2289030; P ϭ 0.0426), however there was no difference in the overall survival
Pioneering design in the field of research of miRNAsassociated SNPs was presented in the study by Landi et al. [57], who selected 3Ј-UTRs of 104 genes as candidates for CRC and identified putative miRNA-binding sites by specialized algorithms (PicTar, DianaMicroT, miRBase, miRanda, TargetScan and microInspector). Fifty-seven SNPs were identified in miRNA-binding sites and evaluated for their ability to affect binding of miRNA to its target, by assessing the variation of Gibbs free energy between the two alleles of each SNP. A total of eight common SNPs were identified and further investigated in a case-control association study. The study was carried out on a series of 968 cases and 697 controls from the Czech Republic, a population with the highest worldwide incidence of CRC. Statistically significant associations were found between CRC risk and variant alleles of CD86 and INSR genes. These observations are the first to report positive associations between SNPs in miRNA-binding regions and cancer risk
Recent studies have found that KRAS mutations predict resistance to monoclonal antibodies targeting the epidermal growth factor receptor in metastatic colorectal cancer (mCRC). Zhang et al. [58] have tested the hypothesis whether SNP in a let-7 microRNA complementary site (lcs6) in the KRAS 3Ј-UTR may be associated with a clinical outcome in 130 KRAS wild-type (KRASwt) mCRC patients enrolled in a phase II study of cetuximab monotherapy (IMCL-0144). KRAS let-7 lcs6 SNP was found to be related to object response rate (ORR) in mCRC patients whose tumours had
Lung cancer
Given the functionality of lcs6, Nelson et al. [62] 
evaluated the hypothesis that this SNP is associated with the occurrence of KRAS mutation as well as survival in a cohort of 218 NSCLC patients. No association was reported between the lcs6 KRAS polymorphism and KRAS mutational status (codon 12).
Furthermore, no association between lcs6 SNP and NSCLC patients survival rate was observed [62] .
Prostate cancer
Recently, many studies suggested that miRNAs are involved in prostate cancer carcinogenesis [7, 8, 17] . To explore whether the intensively studied polymorphism rs2910164 (GϾC) in miR-146a plays any role in prostate cancer, Xu et al. [63] [63] .
Renal cell carcinoma
Horikawa et al. [64] [65] . [66] [66] .
Cervical cancer
In cervical cancer, miR-218 can target laminin-5 ␤3 (LAMB3), but it is suppressed by HPV-16 E6 protein. Because laminin-5 is required in RAS and NF-B blockade induced tumourigenesis of human squamous cell carcinoma and because it is a marker of invasiveness in cervical lesions, Zhou et al.
Ovarian cancer
In a study by Liang et al. [67] 
Gastric cancer
To expand knowledge regarding the new SNP and biological function of miR-27a, Sun et al. [69] [70] .
Bladder cancer
The first study to evaluate the significance of SNPs in miRNA processing pathway genes in bladder cancer predisposition was published by Yang et al. [71] . [78] . Jazdzewski et al. [79] explain this interesting observation in another study of theirs by pointing out a mechanism based on the fact that GC heterozygotes differ from both GG and CC homozygotes by producing three mature microRNAs: one from the leading strand (miR-146a) and two from the passenger strand (miR-146a*G and miR-146a*C), each with a distinct set of target genes [79] .
Moreover, the authors showed that a common G/C polymorphism (rs2910164) within the pre-miR-146a sequence reduced the amount of pre and mature miR-146a from the C allele 1.9-and 1.8-fold, respectively, compared to the G allele. This is followed by a similar decrease in the amount of each pre-miRNAs generated from the corresponding pri-miR-146a in an in vitro processing reaction. The reduction in miR-146a led to less efficient inhibition of target genes involved in the Toll-like receptor and cytokine signalling pathway (TRAF6, IRAK1), and PTC1 (also known as CCDC6 or H4), a gene frequently rearranged with RET proto-oncogene in PTC [79] .
Glioma
In gliomas, only one polymorphism within a mature miRNA sequence, specific rs11614913 gene variant of miR-196a, has ever been studied so far [80] . The [59] and breast cancer [45, 46] , data from glioblastoma cases showed an opposite association between miR-196a genotype and cancer risk, which could be explained by the diversity of tissue origin and subsequent characteristic molecular alterations in different types of cancer [80] . 
Conclusions and future directions
